Results 281 to 290 of about 281,052 (341)

Tracking cancer‐related fatigue during chemotherapy: Insights from a comparative cohort study of early breast cancer patients

International Journal of Cancer, EarlyView.
What's New? Cancer‐related fatigue is a multifactorial symptom commonly experienced by breast cancer patients treated with chemotherapy. Here, the authors investigated the temporal associations between cancer‐related fatigue and exercise capacity to better tailor exercise interventions during chemotherapy.
Joris Mallard, Elyse Hucteau, Roland Schott, Xavier Pivot, Allan F. Pagano, Thomas J. Hureau   +5 more
wiley   +1 more source

Conversion therapy with sintilimab combined with chemotherapy and apatinib in stage IV gastric cancer

International Journal of Cancer, EarlyView.
What's New? In selected patients with stage IV gastric cancer, radical surgery after conversion therapy may increase survival benefit; however, there is currently no standard protocol for conversion therapy. This prospective, single‐arm, single‐center, phase 2 study evaluated the feasibility of adding immunotherapy to a conversion treatment regimen to ...
Yong Liu, Qiang Xue, Baogui Wang, Xuewei Ding, Rupeng Zhang, Xiaona Wang, Bin Ke, Xuejun Wang, Ning Liu, Jingyu Deng, Hongjie Zhan, Bin Li, Liangliang Wu, Mingzhi Cai, Li Zhang, Wenbai Huang, Peng Jin, Han Liang   +17 more
wiley   +1 more source

Interval Cytoreductive Surgery and Cisplatin- or Paclitaxel-Based HIPEC for Advanced Ovarian Cancer.

JAMA Netw Open
González Sánchez S, García Fernández J, Cascales-Campos PA, Gonzalez Gil A, Manzanedo I, Pereira Perez F, Díaz Gómez D, González-de Pedro C, Asensio Diaz E, Pacheco Sanchez D, Prada-Villaverde A, Jaén Torrejimeno I, Lacueva J, Caravaca-Garcia I, Torres-Melero J, Sanchez-García S, Díaz Reques E, Ramírez Plaza C, Gutiérrez-Calvo A, González Bayón L, Morales-Soriano R, López-Mozos F, Bjelic L, Galindo Álvarez J, Marcello Fernandez ME, Turienzo Santos E, Titos García A, Álvarez Seoane R, Artiles Armas M, Garaulet ET, Villarejo Campos P, Boldó Roda E, Rihuete Caro C, García Fadrique A, Arjona-Sánchez Á, REGECOP collaborators.   +35 more
europepmc   +1 more source

New emerging data on adjuvant systemic therapy for stage I HER2 positive breast cancer. [PDF]

Gland Surg
Abdallah H, Crocamo S, de Paula B.
europepmc   +1 more source

Optimizing management of stage IV EGFR mutant non‐small cell lung cancer in Asia: An expert opinion

International Journal of Cancer, EarlyView.
What's New? Emerging strategies for the treatment of advanced non‐small cell lung cancer (NSCLC) featuring epidermal growth factor receptor (EGFR) mutations are helping improve patient outcomes. Which strategies are optimal to effectively manage EGFR‐mutant NSCLC, however, remains unclear.
Gee‐Chen Chang, Akhil Kapoor, Chee Khoon Lee, Chunxia Su, Daniel Chan, Guia Elena Imelda Ladrera, Hye Ryun Kim, Mostafa Aziz Sumon, Moushumi Suryavanshi, Sita Andarini, Tatsuya Yoshida, Thanyanan Reungwetwattana, Tuan Khoi Nguyen, Pei Jye Voon   +13 more
wiley   +1 more source

Combining AdipoRon with Paclitaxel Unveils Synergistic Potential in Non-Small Cell Lung Cancer Cells via AMPK-ERK1/2 Signaling. [PDF]

Cells
Kafeel S, Palmiero G, Salzillo A, Ragone A, Naviglio S, Sapio L.   +5 more
europepmc   +1 more source

Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double‐blind, randomized controlled DHA‐WIN trial

International Journal of Cancer, EarlyView.
What's New? Omega‐3 docosahexaenoic acid (DHA) has shown pleiotropic anti‐cancer effects both in vitro and in animal models. However, clinical evidence of DHA efficacy is limited. This randomized, double‐blind, placebo‐controlled trial tested the efficacy of supplementation with DHA 4.4 g/day during 18 weeks of breast cancer neoadjuvant chemotherapy ...
Jaqueline Munhoz, Marnie Newell, Gilbert Bigras, Susan Goruk, Anil Abraham Joy, Sunita Ghosh, Kerry S. Courneya, Vera Mazurak, Claire M. Douglas, Xiaofu Zhu, Bohdarianna Zorniak, John Mackey, Judith Meza Junco, Julie Price Hiller, Karen King, Sanraj K. Basi, Catherine J. Field   +16 more
wiley   +1 more source

Invasive disease‐free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor‐positive, HER2‐negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial

International Journal of Cancer, EarlyView.
What's New? Neoadjuvant chemotherapy (NACT) can be highly effective for patients with early‐stage breast cancer. Patients with hormone receptor‐positive (HRpos), HER2‐negative (HER2neg) breast cancer, however, may benefit less from NACT. Here, the authors investigated survival outcomes with adjuvant chemotherapy or NACT in a population of ...
Milena Beierlein, Lothar Häberle, Naiba Nabieva, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Christopher Wolf, Hans‐Christian Kolberg, Cosima Brucker, Wolfgang Janni, Peter Dall, Andreas Schneeweiss, Frederik Marme, Marc W. Sütterlin, Matthias Ruebner, Anna‐Katharin Theuser, Nadine M. Hofmann, Sybille Böhm, Katrin Almstedt, Sara Kellner, Paul Gass, Hans‐Joachim Lück, Alexander Hein, Sabine Schmatloch, Matthias Kalder, Christoph Uleer, Ingolf Juhasz‐Böss, Volker Hanf, Christian Jackisch, Volkmar Müller, Brigitte Rack, Erik Belleville, Diethelm Wallwiener, Achim Rody, Claudia Rauh, Chistian M. Bayer, Sabrina Uhrig, Hanna Huebner, Chloë Goossens, Sara Y. Brucker, Carolin C. Hack, Tanja N. Fehm, Peter A. Fasching   +43 more
wiley   +1 more source

Diagnosis and management of gestational trophoblastic disease: 2025 update

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Gestational trophoblastic disease (GTD) arises from abnormal placenta and comprises a spectrum of premalignant to malignant disorders. Changes in the epidemiology of GTD have been noted in various countries. In addition to histology, molecular genetic studies can help in the diagnostic pathway.
Hextan Y. S. Ngan, Michael J. Seckl, Ross S. Berkowitz, Yang Xiang, François Golfier, Paradan K. Sekharan, Antonio Braga, Andrea Garrett   +7 more
wiley   +1 more source